PharmaMarketing Summit 2027 to Convene America's Top Pharmaceutical Marketing Executives in California
Elite industry leaders will gather to address AI-driven engagement, launch excellence, and the future of market access at an exclusive, invitation-only event
Westlake Village, California, January 2027. Marcus Evans will host the PharmaMarketing Summit from 21 to 22 January 2027 at the prestigious Four Seasons Hotel Westlake Village, bringing together America's most influential pharmaceutical commercial and marketing executives for two days of high-level strategic exchange.
Now in its latest edition, the summit continues its tradition of convening senior decision-makers from across the pharmaceutical industry to tackle the challenges reshaping brand performance, commercial strategy, and patient engagement. With the industry undergoing rapid transformation driven by artificial intelligence, shifting patient behaviors, and increasingly complex market access requirements, this year's program is designed to equip attendees with the tools needed to maintain competitive advantage.
The speaker faculty features an impressive roster of pharmaceutical marketing leadership, including Anthony Pugliese, Vice President of Obesity Intelligence & Analytics at Amgen, and Parth Shah, Head of US and Global Value and Access for Obesity at Amgen, who will offer insight into one of the industry's fastest-growing therapeutic categories. Sonia Thomas, Head of Marketing Strategy & Transformation at Conexeu Sciences Inc., will explore how organizations can modernize their marketing operations to keep pace with digital transformation.
Also joining the program is Jeremy Whitelock, Vice President of Global Value and Access at Kailera Therapeutics, addressing the evolving dynamics of payer relationships and value communication. Jackie Polyakov, Director and HCP Immunology Marketing Lead at Keenova Therapeutics, will bring a specialist perspective on precision engagement within immunology. The lineup is further strengthened by Kevyn Adler, Senior Director of Market Access Product and Pipeline Strategy at Regeneron Pharmaceuticals, Brian Nwokorie, Director of Marketing at Takeda, Amanda Svensson Marvel, Senior Marketing Director at Gilead Sciences, and Henry Anderson, Director of Digital Marketing and Omnichannel Operations at Supernus Pharmaceuticals.
Across the two-day program, discussions will center on six core pillars shaping the industry's near-term future: artificial intelligence and next-generation digital marketing, launch excellence and commercial readiness, specialty and rare disease commercialization, market access and pricing strategy, data strategy and health equity, and leadership agility within compliance-driven environments. Sessions will combine keynote presentations, case studies, and interactive forums, offering attendees practical frameworks rather than theoretical discussion alone.
The PharmaMarketing Summit remains strictly invitation-only, ensuring a curated audience of senior pharmaceutical executives alongside carefully vetted solution providers. Marcus Evans, a global media and corporate marketing company with four decades of experience producing premium business events, continues to position the summit as an essential platform for strategic networking and business development within the pharmaceutical sector.
For more information regarding attendance, sponsorship, or speaking opportunities, interested parties are encouraged to contact the Marcus Evans team directly here
